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Abstract
A rich and growing body of literature has emerged on ethics in epidemiologic research and public
health practice. Recent articles have included conceptual frameworks of public health ethics and
overviews of historical developments in the field. Several important topics in public health ethics
have also been highlighted. Attention to ethical issues can facilitate the effective planning,
implementation, and growth of a variety of public health programs and research activities. Public
health ethics is consistent with the prevention orientation of public health. Ethical concerns can be
anticipated or identified early and effectively addressed through careful analysis and consultation.
Introduction
A rich and growing body of literature has emerged on eth-
ics in epidemiologic research and public health practice
[1-11]. Recent articles have included conceptual frame-
works of public health ethics and overviews of historical
developments in the field [7,8,11]. Several important top-
ics in public health ethics have also been highlighted
[7,11,12].
This article provides an overview of ethical issues in epide-
miologic research and public health practice for readers
who do not necessarily have an in-depth knowledge of
public health ethics. In the discussion that follows, a sum-
mary is provided of current definitions and conceptualiza-
tions of public health ethics and key ethical concerns in
the field.
Definitions and conceptualizations of public 
health ethics
The starting point for conceptualizations of public health
ethics has often been general definitions of public health,
such as the definition provided by the Institute of Medi-
cine in 1988: "Public health is what we, as a society, do
collectively to assure the conditions in which people can
be healthy." As noted by Childress et al. [8], "Public health
is primarily concerned with the health of the entire population,
rather than the health of individuals. Its features include an
emphasis on the promotion of health and the prevention of dis-
ease and disability; the collection and use of epidemiological
data, population surveillance, and other forms of empirical
quantitative assessment; a recognition of the multidimensional
nature of the determinants of health; and a focus on the com-
plex interactions of many factors – biological, behavioral,
social, and environmental – in developing effective interven-
tions." Public health activities also include community
collaborations and partnerships for health and the identi-
fication of priorities for public health action.
Previous authors have identified ethical issues and core
values in public health, and highlighted differences and
similarities between public health ethics and other areas
of bioethics [5,7]. Public health ethics, which can be
defined as the identification, analysis, and resolution of
ethical problems arising in public health practice and
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research, has different domains from those of medical eth-
ics. Ethical concerns in public health often relate to the
dual obligations of public health professionals to acquire
and apply scientific knowledge aimed at restoring and
protecting the public's health while respecting individual
autonomy [1,3]. Ethics in public health involves an inter-
play between protecting the welfare of the individual, as
in medicine, and the public health goal of protecting the
public welfare [1]. Other ethical concerns in public health
relate to the need to ensure a just distribution of public
health resources [13]. Public health ethics has a broad
scope that includes ethical and social issues arising in
health promotion and disease prevention, epidemiologic
research, and public health practice [5,7].
In conceptualizing public health ethics and distinguishing
it from other areas of bioethics, previous authors have
often highlighted mandatory or coercive public health
measures that are authorized by public health law (for
example, quarantining people with contagious diseases)
or activities that may infringe upon personal privacy or
autonomy, such as public health surveillance. In many
public health activities there is a tension between con-
cerns over personal liberties and individual autonomy
and public health perspectives, which may be utilitarian,
paternalistic, or communitarian. Communitarian per-
spectives may favor limiting individual autonomy for the
sake of the common good or public interest [7].
Despite the importance of mandatory public health activ-
ities required by law, many examples of voluntary public
health activities can be cited. Public health surveys, for
instance, depend upon the support and informed consent
of members of the public. In deliberating about ethical
questions in their own public health activities, public
health professionals have increasingly referred to explica-
tions of moral reasoning methods useful for public health
research and practice.
Moral reasoning in public health
Moral reasoning involves deliberating about ethical ques-
tions and reaching a decision with the help of judgment
and rational analysis. In such deliberations, particular
decisions and actions may be justified by ethical theory or
an integrated body of rules and principles. Two theories
have commonly been cited in public health research and
practice: deontological and utilitarian [14]. Deontological
theories (sometimes referred to as Kantian theories) hold
that people should not be treated as means to an end and
that some actions are right or wrong regardless of the con-
sequences. Deontological theories provide strong support
for protecting research participants and whole communi-
ties of people, even if protections for human subjects slow
research or the acquisition of knowledge.
Utilitarian theories, on the other hand, strive to maximize
beneficial consequences. The principle of utility requires
aggregate or collective benefits to be maximized. From a
utilitarian perspective, the principle of utility is the ulti-
mate ethical principle from which all other principles are
derived [14]. Utilitarian theories provide strong justifica-
tion for public health programs such as mandatory vacci-
nation programs for children and the fluoridation of
public water supplies.
Different methods of moral reasoning have been applied
to ethical decision making in public health research and
practice [5]. Two approaches have figured most promi-
nently: the principle-based approach to moral reasoning
explicated by Beauchamp and Childress, and case-based
methods such as casuistry [15].
Principle-based approaches
Principle-based approaches to moral reasoning were
developed to address ethical issues in clinical medicine
and are not necessarily the optimal approach for analyz-
ing ethical issues in public health. The four principles of
beneficence, nonmaleficence, justice, and respect for
autonomy are mentioned in ethics guidelines drafted for
public health professionals, although the guidelines do
not provide an exhaustive account of how the principles
can be used as a framework for ethical decision making
[9,16]. Principles such as justice also figure prominently
in still-evolving ethics frameworks that have been pro-
posed for public health [8,11,13].
The principles of beneficence, nonmaleficence, auton-
omy, and justice, as explained by Beauchamp and Chil-
dress [17], seek to reduce morality to its basic elements
and to provide a useful framework for ethical analysis in
the health professions. The principles do not provide a
full philosophical justification for decision making, how-
ever. In situations where there is conflict between princi-
ples, it may be necessary to choose between them or to
assign greater weight to one. Practical problems in public
health ethics require that these principles be made more
applicable through a process of specification and reform
[14]. Ongoing progressive specification is needed as new
issues and concerns arise.
The ethical principle of beneficence requires that potential
benefits to individuals and to society be maximized and
that potential harms be minimized [17]. Beneficence
involves both the protection of individual welfare and the
promotion of the common welfare. This principle under-
lies ethical rules and norms that require that public health
institutions act in a timely manner on the information
they have and that they expeditiously make the informa-
tion available to the public [9]. The principle of nonma-
leficence requires that harmful acts be avoided. However,Emerging Themes in Epidemiology 2006, 3:16 http://www.ete-online.com/content/3/1/16
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the principle of nonmaleficence does not preclude balanc-
ing potential harms against potential benefits [14]. The
principle of autonomy focuses on the right of self-deter-
mination. Respect for the individual is a principle rooted
in the Western tradition, which grants importance to indi-
vidual freedom in political life, and to personal develop-
ment.
Principles of justice are also important [11,13,14]. Utili-
tarian theories of justice emphasize a mixture of criteria so
that public utility is maximized. From this perspective, a
just distribution of benefits from public health programs
or research is determined by the utility to all affected. As
noted by Childress et al. [8], public health activities are
generally understood to be consequentialist in that the pri-
mary end that is sought is the health of the public. An
egalitarian theory of justice holds that each person should
share equally in the distribution of the potential benefits
of health care resources such as screening services. Other
theories of justice hold that society has an obligation to
correct inequalities in the distribution of resources, and
that those who are least well off should benefit most from
resources such as screening services. Such theories of jus-
tice provide considerable support for maximizing benefits
to medically underserved people [13,18].
Case-based approaches to moral reasoning
While many general ethical questions have been answered
on the basis of general principles and theories, the specific
decisions that emerge in particular cases may remain
unaddressed by the principles. Such decisions are often
made by focusing on the circumstances of the case at hand
and the moral context in which the case rests. Case-based
methods such as casuistry are grounded in analogical rea-
soning, appeal to paradigmatic cases, and practical judg-
ment [5,14].
In casuistry, which in contemporary bioethics has been
championed by Albert Jonsen and Stephen Toulmin
[15,19], decision making takes place at the level of the
particulars of the case itself. Given a case and a particular
decision to be made, a casuist need not refer directly to a
particular theory. Rather, maxims are identified that have
bearing on the case. Maxims are wise, pithy, rule-like say-
ings such as "tell the truth" or "be compassionate."
Casuistry requires a clear exposition of the facts that sur-
round a case. A decision must then be made about which
maxim is the most appropriate to "rule" or govern the
case. Different circumstances or facts might call for a dif-
ferent maxim. A claim or judgment is then made regard-
ing the case. The claim is backed by a form of logical
reasoning described in terms of grounds or relevant cir-
cumstances, maxims, and the backings or more general
notions that support the maxims. The descriptions of the
case, including the circumstances, maxims, and logical
thought, constitute its basic structure or morphology [14].
Placing a particular case alongside other similar cases has
been referred to as taxonomy.
Casuistic reasoning begins with relatively clear, paradig-
matic cases in which some ethical norm indicates the right
course of action. Judgment is necessary to determine
which norm applies in a complicated or ambiguous case.
Other approaches to moral reasoning
Other approaches to moral reasoning, such as rights-
based theories, duty-based theories, contractarianism, the
ethics of care, narrative ethics, and communitarianism
have not been widely applied in public health. Virtue eth-
ics and the moral rule-based system of Gert and Clouser,
however, have been discussed as potential alternatives to
other leading approaches to moral reasoning in public
health ethics [5,20].
Moral disagreements can sometimes be resolved by
obtaining further facts about matters at the center of the
controversy or by more clearly defining the language used
by the disputing parties [14]. Other steps that can be taken
to resolve moral controversies include using examples and
counter-examples and analyzing arguments to expose
their inadequacies, gaps, and fallacies. In addition, moral
problems can sometimes be resolved by getting the dis-
puting parties to adopt a new policy or code, such as ethics
guidelines for epidemiologists [14].
Ethical issues in epidemiology and public health 
practice
The results of epidemiologic research studies contribute to
generalizable knowledge by elucidating the causes of dis-
ease; by combining epidemiologic data with information
from other disciplines such as genetics and microbiology;
by evaluating the consistency of epidemiologic data with
etiological hypotheses; and by providing the basis for
developing and evaluating health promotion and preven-
tion procedures [21]. The primary professional roles of
epidemiology are the design and conduct of scientific
research and the public health application of scientific
knowledge. This includes reporting research results and
maintaining and promoting health in communities. In
carrying out these professional roles, epidemiologists
often encounter a number of ethical issues and concerns
that require careful consideration. Many of these issues
have been addressed in the literature on ethics in epidemi-
ology and public health practice including ethics guide-
lines.Emerging Themes in Epidemiology 2006, 3:16 http://www.ete-online.com/content/3/1/16
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Issues dealt with in ethics guidelines for 
epidemiologists and the published literature
Ethical and professional norms in epidemiology have
been clarified in ethics guidelines for epidemiologists and
other public health professionals [16,22-24]. Ethics
guidelines such as those developed for the Industrial Epi-
demiology Forum, the International Society for Environ-
mental Epidemiology, and the American College of
Epidemiology provide useful accounts of epidemiologists'
obligations to research participants, society, employers,
and colleagues. Ethics guidelines for environmental epi-
demiologists drafted by Colin Soskolne and Andrew
Light, which were adopted by the International Society for
Environmental Epidemiology in 1999, highlight the
important obligations that epidemiologists have to com-
munities that are affected by environmental hazards [22].
The ethics guidelines adopted by the American College of
Epidemiology discuss core values, duties, and virtues in
epidemiology; the professional role of epidemiologists;
minimizing risks and protecting the welfare of research
participants; providing benefits; ensuring an equitable
distribution of risks and benefits; protecting confidential-
ity and privacy; obtaining informed consent; submitting
proposed studies for ethical review; maintaining public
trust; avoiding conflicts of interest and partiality; commu-
nicating ethical requirements; confronting unacceptable
conduct; and obligations to communities [16]. Interna-
tional guidelines for ethical review of epidemiologic stud-
ies were published by the Council of International
Organizations of Medical Sciences [24]. The CIOMS
guidelines draw a distinction between epidemiologic
research and routine practice (for example, outbreak
investigations and public health surveillance) and con-
sider some of the issues associated with obtaining
informed consent in epidemiologic studies. Specific ethi-
cal issues arising in epidemiologic research and public
health practice that have been highlighted in ethics guide-
lines include minimizing risks and providing benefits,
informed consent, avoiding and disclosing conflicts of
interest, obligations to communities, and the institutional
review board system.
Minimizing risks and providing benefits
Ethical concerns in epidemiology and public health prac-
tice often relate to the obligations of health professionals
to acquire and apply scientific knowledge aimed at main-
taining and restoring public health while respecting indi-
vidual rights. Potential societal benefits must often be
balanced with risks and potential harms to individuals
and communities, such as the potential for stigmatization
or invasions of privacy.
Epidemiologists have ethical and professional obligations
to maximize the potential benefits of studies to research
participants and to society, and to minimize potential
harms and risks. In addition, these obligations are often
legal or regulatory requirements, such as U.S. federal reg-
ulations protecting human research participants (45 CFR
46). The risks of epidemiologic studies and practice activ-
ities can be minimized by rigorously protecting the confi-
dentiality of health information, as discussed below.
Although the risks posed by epidemiologic studies are
often minor compared with those that may be associated
with clinical trials and other experimental studies, partic-
ipants in epidemiologic studies may be burdened by a loss
of privacy, by time spent completing interviews and exam-
inations, and by possible adverse psychological effects
such as enhanced grief or anxiety [25]. Such risks and
potential harms can be minimized by careful attention to
study procedures and questionnaire design, for example,
by limiting the length of interviews or by scheduling them
on a date that is less likely to result in adverse psycholog-
ical effects.
Minimizing risks and potential harms and maximizing
potential benefits are particularly important in epidemio-
logic studies of vulnerable populations. Examples include
studies of children, prisoners, some elderly people, and
populations that are marginalized or socioeconomically
disadvantaged.
A further obligation is the need to ensure that the burdens
and potential benefits of epidemiologic studies are dis-
tributed equitably. The potential benefits of epidemio-
logic research are often societal in nature, such as
obtaining new information about the causes of diseases,
or identifying health disparities across groups defined by
race, ethnicity, socioeconomic status, or other factors [25].
Research participants may receive direct benefits from par-
ticipation in some studies, such as when a previously
unrecognized disease or risk factor is detected during
examinations. The balance of risks and potential benefits
of epidemiologic studies are considered not only by indi-
vidual researchers but also by members of human subjects
committees such as institutional review boards in the
United States.
Avoiding and disclosing conflicts of interest
Other ethical issues that arise in the professional practice
of epidemiology relate to how best to deal with potential
conflicts of interest, in order to maintain public trust in
epidemiology and sustain public support for health
research. Recent media reports about previously undis-
closed conflicts of interest in the United States and other
countries have raised public awareness of the potential for
conflicts of interest in clinical research and epidemiology,
and about the need for institutions and individual
researchers to address such conflicts. Conflicts of interest
can affect scientific judgment and harm scientific objectiv-
ity. Studies have suggested that financial interests andEmerging Themes in Epidemiology 2006, 3:16 http://www.ete-online.com/content/3/1/16
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researchers' commitment to a hypothesis can influence
reported research results [26]. To address such concerns,
funding agencies and research institutions have taken
steps such as adopting new training programs that encour-
age researchers to avoid or disclose conflicts of interest,
and revising or strengthening institutional rules and
guidelines. Professional societies and medical associa-
tions have also issued policy statements and recommen-
dations about how best to address conflicts of interest in
clinical research [27]. Researchers should disclose finan-
cial interests and sources of funding when publishing
research results. It may also be important to disclose infor-
mation about potential or actual financial conflicts of
interest when obtaining informed consent from research
participants. A related issue is that health researchers
should avoid entering into contractual agreements that
prevent them from publishing results in a timely manner
[16]. Communicating research results in a timely manner,
without censorship or interference from the funder, is
essential for maintaining public trust [9].
Obligations to communities
The obligations of epidemiologists to study participants
have been highlighted in several reports [16,22]. These
obligations include communicating the results of epide-
miologic studies at the earliest possible time, after appro-
priate scientific peer review, so that the widest possible
audience stands to benefit from the information. Epide-
miologists should strive to carry out studies in a way that
is scientifically valid and interpret and report the results of
their studies in a way that is scientifically accurate and
appropriate. In addition, epidemiologists should respect
cultural diversity in carrying out studies and in communi-
cating with members of affected communities. Other obli-
gations to community members and to research
participants have been highlighted in ethics guidelines for
epidemiologists and public health institutions [9].
Informed consent
Informed consent provisions in public health studies
ensure that research participants make a free choice and
also give institutions the legal authorization to proceed
with the research [28]. Investigators must disclose infor-
mation that potential participants use to decide whether
to consent to the study. This includes the purpose of the
research, the scientific procedures, anticipated risks and
benefits, any inconveniences or discomfort, and the par-
ticipant's right to refuse participation or to withdraw from
the research at any time [45 Code of Federal Regulations
(CFR) 46]. Informed consent requirements may be
waived in exceptional circumstances when obtaining con-
sent is impractical, the risks are minimal, and the risks and
potential benefits of the research have been carefully con-
sidered by an independent review committee. For exam-
ple, in some epidemiology studies involving the analysis
of large databases of routinely collected information (for
example, insurance claims data), it may not be feasible to
recontact patients to ask them for their informed consent.
Risks and potential harms in such studies may be very
low, and risks may be further reduced by omitting per-
sonal identifiers from the computer databases.
Special considerations for obtaining informed consent
may arise in public health studies of socioeconomically
deprived people. People who have limited access to health
care may misunderstand an invitation to participate in a
study as an opportunity to receive medical care. In addi-
tion, they may be reluctant to refuse participation when
the researcher is viewed as someone in a position of
authority, such as a physician or university professor.
Socioeconomically deprived people may also be more
motivated to participate in studies involving financial
incentives for participation. A further issue is that there is
often a need to translate informed consent statements
into a language other than English. The important issues
that arise in international research conducted by research-
ers from countries such as the United States and Great
Britain in developing countries have also received consid-
erable attention [24,29].
Privacy and confidentiality
One important way in which public health researchers
reduce potential harms and risks to participants in epide-
miologic studies is by rigorously protecting the confiden-
tiality of their health information. Specific measures taken
by researchers to protect the confidentiality of health
information include keeping records under lock and key,
limiting access to confidential records, discarding per-
sonal identifiers from data collection forms and computer
files whenever feasible, and training staff in the impor-
tance of privacy and confidentiality protection [25]. Other
measures that have been employed to safeguard health
information include encrypting computer databases, lim-
iting geographic detail, and suppressing cells in tabulated
data where the number of cases in the cell is small [30].
In the United States, the Health Insurance Portability and
Accountability Act (HIPAA) of 1996 took effect early in
2004 after extensive planning and discussion [31]. The
new regulations provide protection for the privacy of cer-
tain individually identifiable health data, referred to as
protected health information. The privacy rules permit
disclosures without individual authorization to public
health authorities authorized by law to collect or receive
the information for the purpose of preventing or control-
ling disease, injury, or disability, including public health
practice activities such as surveillance.Emerging Themes in Epidemiology 2006, 3:16 http://www.ete-online.com/content/3/1/16
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The institutional review board system
The purpose of research ethics committees or institutional
review boards (IRBs) is to ensure that studies involving
human research participants are designed to conform
with relevant ethical standards and that the rights and
welfare of participants are protected. Human-subjects
review by such committees ensures that studies have a
favorable balance of potential benefits and risks, that par-
ticipants are selected equitably, and that procedures for
obtaining informed consent are adequate. In the United
States, federal regulations to protect human research sub-
jects (45 CFR 46) have resulted in a complex IRB system.
Similar safeguards exist in many other countries.
Despite the important role played by research ethics com-
mittees and IRBs, researchers have sometimes expressed
concern about the obstacles that human-subjects review
can create. In some countries, human-subjects review has
been streamlined with the use of standardized forms and
review processes or by centralizing review by research eth-
ics committees [32]. As previously mentioned, one of the
important issues considered by research ethics commit-
tees and by individual researchers is the adequacy of pro-
visions for obtaining the informed consent of study
participants.
These are just some of the ethical issues addressed in eth-
ics guidelines developed for epidemiologists and other
public health professionals. Other issues addressed in the
guidelines include those pertaining to scientific miscon-
duct, intellectual property and data sharing, publication
of research findings, and cross-cultural or international
health research.
Ethical issues in public health practice
An expanding body of literature has considered the
important ethical issues that arise in such areas of public
health practice as surveillance, emergency responses, and
program evaluation [1,4,33-35]. In further specifying eth-
ical norms in particular contexts, it is important to draw
distinctions between epidemiologic research and public
health practice activities. For example, requirements for
submitting research protocols to an IRB do not necessarily
apply to outbreak investigations and other emergency
responses [36].
Definitions of surveillance, emergency responses, and 
program evaluation
Surveillance can be defined as the ongoing, systematic col-
lection, analysis, and interpretation of outcome-specific
data, with the timely dissemination of these data to those
responsible for preventing and controlling disease or
injury [37]. A fundamental public health activity is to
measure and monitor changes in health status, risk fac-
tors, and health service access and utilization. The effec-
tive dissemination of information is as important as data
collection and analysis; the collected information must
have a demonstrated utility [38].
Emergency responses and outbreak investigations can be
defined as public health activities undertaken in an urgent
or emergency situation, usually because of an imminent
health threat to the population [39]. Sometimes this is
because the public or government authorities perceive an
imminent threat that demands immediate action. The pri-
mary purpose of the activity is to determine the nature
and magnitude of a public health problem in the commu-
nity and to implement appropriate measures to address
the problem [39].
Field epidemiology and investigations of disease out-
breaks require us to consider when the data are sufficient
to take action rather than to ask what additional questions
might be answered by the data [40]. The guidelines and
approaches for conducting epidemiologic field investiga-
tions reflect the urgency of discovering causative factors
and the need to make practical recommendations, such as
during the SARS epidemic [41]. Program evaluation, on
the other hand, refers to the systematic application of sci-
entific and statistical procedures for measuring program
conceptualization, design, implementation, and utility;
the comparison of these measurements; and the use of the
resulting information to optimize program outcomes
[36,42,43].
Federal regulations (Title 45 CFR Part 46), which deal
with issues such as IRB review and informed consent
requirements, mostly address biomedical research
[36,42,43]. These regulations define research as a system-
atic investigation, including development, testing, and
evaluation designed to develop or contribute to generaliz-
able knowledge. Although some public health activities
can clearly be classified as either research or non-research
activities for regulatory purposes, for other activities the
classification is more difficult. For example, scientific
knowledge generated in controlling a disease outbreak
may turn out to be useful in other settings, even though
generating generalizable knowledge was not the primary
intent of the investigation [36].
In applying the federal regulations for protecting partici-
pants in public health research, U.S. agencies have distin-
guished health research and non-research public health
practice activities. Research and non-research activities
cannot be easily defined by the methods that are
employed. For example, questionnaire development, lab-
oratory analysis, and logistic regression techniques are
commonly employed in etiologic studies with a case-con-
trol design, as well as in many case-control studies con-
ducted as part of outbreak investigations. To address thisEmerging Themes in Epidemiology 2006, 3:16 http://www.ete-online.com/content/3/1/16
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issue, guidelines from the Centers for Disease Control and
Prevention state that the major difference between
research and non-research lies in the primary intent of the
activity. The primary intent of research is to generate or
contribute to generalizable knowledge. The primary
intent of non-research activities in public health practice
is to prevent disease or injury, improve health, and ensure
the efficient and effective use of resources.
For example, surveillance projects are likely to be non-
research when they involve the regular, ongoing collec-
tion and analysis of health-related data, conducted to
monitor the frequency and distribution of diseases and
health conditions in the population. Surveillance projects
may have a research component when they involve the
collection and analysis of health-related data conducted
either to generate knowledge that is applicable to other
populations and settings or to contribute to general
knowledge about the health condition. Most emergency
responses and outbreak investigations tend to be non-
research because these projects are undertaken to solve an
immediate health problem and any knowledge gained
will likely benefit only the study participants or target
population [36].
Although some ethical requirements, such as IRB review,
do not apply equally to epidemiologic research and non-
research public health practice activities, there are many
important similarities between the ethics of epidemio-
logic research and non-research (for example, require-
ments for confidentiality protection in research and non-
research disease surveillance systems). Investigators
should carefully consider ethical issues in each project,
regardless of whether it is research or public health prac-
tice.
Ethical issues in public health surveillance
Ethics guidelines for public health surveillance have been
developed for disease registry personnel, and a growing
body of literature has evolved in this area, indicating
increasing interest [4,33-35,44]. These developments are
partly a response to public concern over the privacy and
confidentiality of health information and technological
advances such as the use of the Internet to disseminate
data from surveillance systems and disease registries.
Data collected through surveillance systems provide for
the ongoing evaluation of disease risk factors, incidence,
and mortality, and allow for the evaluation of health care
utilization, treatment, and disease prevention and control
activities [45]. These and other benefits of public health
surveillance must be balanced against possible risks and
harms, such as infringements on personal privacy. The
need to balance potential benefits against risks underlines
the rule that surveillance data should not be collected if
they will not be used [44]. Thus, public health profession-
als have ethical obligations to both maximize the poten-
tial benefits of routinely collected surveillance and disease
registry data and minimize risks and potential harms.
Steps taken to assure the quality of data collected by pub-
lic health surveillance systems and disease registries max-
imize the potential benefits of the data. Registry data must
be accurate, complete, and timely.
Potential harms and risks from the collection and use of
surveillance and registry data include loss of privacy and
harms resulting from breaches of confidentiality. These
risks are remote possibilities because of the steps taken by
public health professionals to safeguard the confidential-
ity of personally identifiable records in surveillance sys-
tems and registries, such as data encryption, written
policies and procedures for confidentiality and disclosure
of data, and training of staff.
The privacy rules included in HIPAA permit disclosures
without individual authorization to public health author-
ities who can legally collect or receive the information for
the purpose of preventing or controlling disease, injury, or
disability. This includes public health practice activities
such as surveillance.
Health promotion and disease prevention
The potential benefits of disease prevention and health
promotion efforts include a healthier society and reduced
fiscal expenditure and increased productivity and effi-
ciency [46]. Individual members of society can also bene-
fit. There is a need to balance health as a value with values
of privacy and autonomy (for example, in relation to
immunization policies). Several authors have considered
the circumstances under which personal autonomy can be
abridged to promote the health of the whole community
and the moral justification for coercive public health
interventions and lifestyle strategies [47,48]. As noted by
Lappe [1], "From an ethical perspective, the extent to which
[compulsive public health] interventions are justified depends
on... the anticipated extent and kind of public benefit; the
degree to which individual rights are restricted to achieve that
benefit; and the ultimate distribution of both benefits and
harms attendant to participation."
In general, there is a need for voluntariness in health edu-
cation, health promotion, and public health communica-
tion programs. The risks and potential harms of public
health interventions include ineffective, counterproduc-
tive, or harmful interventions; unanticipated conse-
quences; and labeling or stigmatizing of individuals [49].
Undue stress upon the individual's role in the cause of ill-
ness could lead to a "blame the victim" mentality [48].
The dilemma is how to advise people that they might be
at risk for potentially serious health complications with-Emerging Themes in Epidemiology 2006, 3:16 http://www.ete-online.com/content/3/1/16
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out labeling them, contributing to their anxiety, or
adversely affecting their well-being [49].
Ethical considerations for prevention trials and commu-
nity interventions include an assessment of risks and ben-
efits, the need for voluntary participation and avoidance
of excessive incentives, and justice-related issues. There is
a need for sensitivity to ethnic and cultural habits and
norms and to avoid "top-down" planning, in which the
health concerns and self-defined information needs of the
target population are ignored in favor of professional pre-
occupations and concerns. Such concerns have been suc-
cessfully addressed through community-based
participatory research, which is a collaborative, empower-
ing process that helps develop competencies in communi-
ties [50]. Ethical issues in health communication include
the need to avoid conflicts of interest, to present facts
about health hazards or health opportunities in a truthful,
balanced, and timely fashion, and to avoid distorting the
facts or concealing ambiguities in the scientific evidence
[49].
Ethical issues in screening
Ethical issues also arise in public health screening pro-
grams [51]. Screening is the presumptive identification of
an unrecognized disease or condition by the use of tests,
examinations, or other procedures that can help identify a
disease or disease precursor in apparently well people.
People with positive or suspicious findings then undergo
further evaluation or treatment. The ultimate objective of
screening is to reduce the morbidity or mortality from a
disease among the people screened.
Several frameworks for analyzing and addressing ethical
and policy issues in public health screening programs
have been proposed. In 1968, Wilson and Jungner [52]
proposed 10 principles for mass screening programs.
These principles are often cited in planning and evaluat-
ing population screening programs; they relate to the ade-
quacy of the scientific evidence, the balance of risks and
benefits, the availability of an effective treatment, the
acceptability of the screening test to the population, and
the costs and resources required [51]. Refinements have
been proposed over the years, with further specification of
the principles of screening [53-56]. Criteria for the effec-
tiveness of clinical preventive services have been devel-
oped by the Canadian Task Force on the Periodic Health
Examination [57] and by the U.S. Preventive Services Task
Force [58]. Screening raises a number of important ethical
issues around informed consent, privacy and confidenti-
ality, risks and potential benefits, and the allocation of
finite public resources for screening.
The principle of respect for individuals' freedom supports
the right of participants to informed consent prior to
screening [51]. Provisions for informed consent ensure
that people undergoing screening make free choices, and
encourage providers to act responsibly in their interac-
tions with patients. Subjects should be given information
about the procedure, the meaning of a positive or negative
test result, and any appreciable risks or potential harms
and benefits before undergoing screening [51]. To give
informed consent for screening, participants need to
understand the risk of a false-positive test result and the
procedures that may follow it [59].
Principles of informed consent for screening have some
features in common with emerging models of informed
decision making and shared decision making for screen-
ing and other health care services [60]. Such models
emphasize that people should be provided with balanced
and relevant information so they can make informed deci-
sions about screening options [61-63]. As discussed by
Briss et al. [62], informed decision making occurs when
the participant understands the nature of the disease or
condition being addressed; understands the clinical serv-
ice and its likely consequences, including risks, limita-
tions, benefits, alternatives, and uncertainties; has
considered his or her preferences as appropriate; has par-
ticipated in decision making at a personally desirable
level; and either makes a decision consistent with his or
her preferences and values or elects to defer a decision to
a later time.
Although public health screening is generally voluntary,
some examples of mandatory screening can be cited. For
example, most states require that infants be screened for
certain genetic disorders, such as phenylketonuria (PKU).
Infants are subject to the screening program unless their
parents refuse for religious or philosophical reasons [51].
Public health officials may justify mandatory newborn
screening programs, even without parental consent, under
utilitarian principles authorizing state governments to
protect children [51].
The potential benefits of screening include the early detec-
tion of disease and the prevention of serious illness or dis-
ability and improved survival. The societal benefits of
screening include substantial reductions in morbidity and
mortality [58]. Screening is undertaken for conditions
that are important public health problems and those for
which early detection and treatment are effective. If early
treatment is not effective, then early detection alone
merely extends the length of time the disease is known to
exist, without extending survival [59]. Public health policy
makers rely on information from randomized controlled
trials and other sources to evaluate the effectiveness,
potential benefits, and risks or potential harms of screen-
ing.Emerging Themes in Epidemiology 2006, 3:16 http://www.ete-online.com/content/3/1/16
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The potential harms and risks associated with screening
also have to be taken into account, especially since screen-
ing programs are aimed at large numbers of apparently
healthy people. Minor complications or infrequent
adverse effects that would be acceptable in the treatment
of a severe illness take on greater importance when screen-
ing asymptomatic people and require careful evaluation
to determine whether the potential benefits exceed risks
[58]. There may be risks associated with false-positive or
false-negative test results. The potential harms of screen-
ing may also include "labeling" effects and the psycho-
logic impact of test results or a diagnosis. If prognosis is
not improved by presymptomatic detection, screening for
a disease can cause anxiety without providing any benefit
[56]. Medical information collected as part of screening
should be rigorously safeguarded to protect patient pri-
vacy and confidentiality and to minimize risks or poten-
tial harms such as stigma or discrimination. Only a few
specific exceptions exist, such as mandatory partner noti-
fication laws for HIV infection that physicians are legally
required to follow in some states [64].
Summary and conclusion
The burgeoning interest in ethical issues in epidemiologic
research and public health practice reflects both the
important societal role of public health and the growing
public interest in the scientific integrity of health informa-
tion and the equitable distribution of health care
resources. Attention to ethical issues can facilitate the
effective planning, implementation, and growth of a vari-
ety of public health programs and research activities. Seen
from this perspective, public health ethics is consistent
with the prevention orientation of public health. Ethical
concerns can be anticipated or identified early and effec-
tively addressed through careful analysis and consulta-
tion.
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